Universal Registration Document

Overview

The report describes MedinCell's 2022/2023 progress, including the UZEDY schizophrenia treatment's U.S. approval and launch. It highlights a dedicated ESG Committee at Supervisory Board level, a double-materiality analysis and expansion of the carbon footprint to Scope 3. The report also presents detailed workforce, energy, water, waste and emissions indicators, supported by limited independent third-party assurance.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Publication date: 28 July 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview